Herantis Pharma Oyj - ESG Rating & Company Profile powered by AI

Industry Group:Pharmaceuticals

This article contains a questions and answers section on Herantis Pharma Oyj. The webpage displays a zero-cost ESG report for Herantis Pharma Oyj. Alternative companies in the rating industry group for Herantis Pharma Oyj are displayed.

Herantis Pharma Oyj in the Pharmaceuticals industry gained a UN SDG ESG Transparency Score of 2.4; made up of an environmental score of 0.0, social score of 4.0 and governance score of 3.2.

green chameleon

1/10 free views/searches used

You're viewing a Free Open ESG Rating.
To access the most comprehensive ESG data experience, Sign up to SEVVA Platform.

SDG Transparency Score for Herantis Pharma Oyj 

2.4

Low Impact
0 - 3
Medium
4 - 6
High
7 - 10
Last Score Update: 2022-07-01
What drives the score for Herantis Pharma Oyj 
0.0

Environmental

4.0

Social

3.2

Governance

Detailed ESG Breakdown
SEVVA Platform offers unique drill down to the underlying sources powering the ratings. Break down your ESG analysis by 17 UN SDGs and 8 additional governance factors.

Peer Group Comparison

RankCompanySDG Transparency Score Performance
1Novartis AG
9.8
High
2Eli Lilly and Co
9.5
High
.........
2190Sol Gel Technologies Ltd
2.5
Medium
2190iNtRON Biotechnology Inc
2.5
Medium
2218Herantis Pharma Oyj
2.4
Medium
2218Mabion SA
2.4
Medium
2218Naturalendo Tech Co Ltd
2.4
Medium
.........
2690Zyden Gentec Ltd
0.0
Low
2690Zyla Life Sciences
0.0
Low
.........
View the full peer group of 3274 companies on the SEVVA platformSign up for free
Peer Companies Benchmark
SEVVA Platform benchmarks each company against a peer group. View the full score distribution for peers by logging into SEVVA

Frequently Asked Questions

Does Herantis Pharma Oyj reference operational or capital allocation in relation to climate change?No
No answer found for the question

Is Capital Expenditure linked to emissions reduction?

Only SubscribersSubscription required
Does the Board describe its role in the oversight of climate-related risks and opportunities?No
No answer found for the question

Has Herantis Pharma Oyj submitted or committed to submit to a shareholder vote (say-on-climate) its climate strategy?

Only SubscribersSubscription required
Does Herantis Pharma Oyj disclose current and historical air emissions?

Does Herantis Pharma Oyj disclose current and / or historical ozone-depleting emissions?

LockedSign up for free to unlock
Does Herantis Pharma Oyj disclose current and / or historical scope 1 emissions?
Does Herantis Pharma Oyj disclose current and / or historical scope 2 emissions?

Does Herantis Pharma Oyj disclose current and / or historical scope 3 emissions?

Only SubscribersSubscription required

Does Herantis Pharma Oyj disclose current and / or historical emissions broken down by scope?

Only SubscribersSubscription required
Does Herantis Pharma Oyj disclose GHG and Air Emissions intensity?

Does Herantis Pharma Oyj disclose GHG Targets?

LockedSign up for free to unlock

Does Herantis Pharma Oyj disclose data for NOx, SOx and VOCs emissions?

LockedSign up for free to unlock

Does Herantis Pharma Oyj disclose its Scope Emissions targets?

Only SubscribersSubscription required
Does Herantis Pharma Oyj disclose current and historical energy intensity?

Does Herantis Pharma Oyj disclose its current and / or historical energy use?

LockedSign up for free to unlock

Does Herantis Pharma Oyj disclose energy use targets?

LockedSign up for free to unlock

Does Herantis Pharma Oyj disclose its Renewable Energy targets?

Only SubscribersSubscription required

Does Herantis Pharma Oyj disclose its biodiversity policy?

LockedSign up for free to unlock

Does Herantis Pharma Oyj disclose its forestry policy?

LockedSign up for free to unlock

Does Herantis Pharma Oyj disclose its internal carbon price?

Only SubscribersSubscription required

Does Herantis Pharma Oyj disclose long-term targets (>5 years) for reducing its GHG emissions?

LockedSign up for free to unlock

Does Herantis Pharma Oyj disclose Scope 3 emissions from use of sold products?

Only SubscribersSubscription required

Does Herantis Pharma Oyj disclose current and historical material use?

LockedSign up for free to unlock
Are Operating Expesnses linked to emissions reduction?
Does Herantis Pharma Oyj disclose climate scenario or pathway analysis?
Does Herantis Pharma Oyj reflect climate-related risks in its financial statements?

Does Herantis Pharma Oyj disclose the number and percentage of companies screened by environmental and social criteria?

Only SubscribersSubscription required

Are emissions metrics verified by CDP?

Only SubscribersSubscription required

Are emissions metrics verified by STBi?

Only SubscribersSubscription required
Does Herantis Pharma Oyj report according to TCFD requirements?

Does Herantis Pharma Oyj disclose current and historical waste generation?

LockedSign up for free to unlock

Does Herantis Pharma Oyj disclose current and / or historical waste management?

Only SubscribersSubscription required

Does Herantis Pharma Oyj disclose waste targets?

Only SubscribersSubscription required

Has Herantis Pharma Oyj published clear targets on waste management?

LockedSign up for free to unlock

Does Herantis Pharma Oyj disclose current and / or historical water consumption?

Only SubscribersSubscription required
Does Herantis Pharma Oyj disclose its waste policy?
Does Herantis Pharma Oyj disclose water use targets?
Does Herantis Pharma Oyj condunt supply chain audits?

Does Herantis Pharma Oyj engage third parties to conduct supply chain audit?

LockedSign up for free to unlock

Does Herantis Pharma Oyj disclose board meeting attendance?

LockedSign up for free to unlock

Are there worker representatives on the board?

LockedSign up for free to unlock

Does Herantis Pharma Oyj disclose long term financial targets?

Only SubscribersSubscription required

Does Herantis Pharma Oyj report NPS (customer loyalty, customer churn or satisfaction surveys) ?

LockedSign up for free to unlock

Does Herantis Pharma Oyj report customer churn rates?

Only SubscribersSubscription required

Does Herantis Pharma Oyj have a policy relating to cyber security?

LockedSign up for free to unlock
Does Herantis Pharma Oyj disclose cybersecurity risks?

Does Herantis Pharma Oyj adhere to ISO 27001 / ISO 27002 standards or the NIST cybersecurity framework?

Only SubscribersSubscription required

Does Herantis Pharma Oyj conduct cybersecurity training?

Only SubscribersSubscription required
Does Herantis Pharma Oyj disclose the individual responsible for D&I?
Does Herantis Pharma Oyj conduct 360 degree staff reviews?

Does Herantis Pharma Oyj have engagement surveys, a culture survey, a pulse survey?

LockedSign up for free to unlock
Does Herantis Pharma Oyj have a long term incentive (LTI) executive compensation plan based on a measure of return on capital?

Does Herantis Pharma Oyj disclose the vesting percentage required for performance threshold in the LTIP?

Only SubscribersSubscription required
Has Herantis Pharma Oyj issued a profit warning in the past 24 months?
Does Herantis Pharma Oyj report the average age of the workforce?

Does Herantis Pharma Oyj report internal employee trust metrics such as ENPS?

LockedSign up for free to unlock

Does Herantis Pharma Oyj permit its workforce to engage in collective bargaining?

LockedSign up for free to unlock

Does Herantis Pharma Oyj disclose average employee tenure?

Only SubscribersSubscription required

Does Herantis Pharma Oyj refer to human capital or people risk in its risk disclosures?

Only SubscribersSubscription required

Does Herantis Pharma Oyj promote decent work conditions in relation to its supply chain?

LockedSign up for free to unlock
Does Herantis Pharma Oyj allow for Work Councils/Collective Agreements to be formed?

Does Herantis Pharma Oyj report the number of strikes or work related stoppages?

LockedSign up for free to unlock
Does Herantis Pharma Oyj have an accelerator or VC vehicle to help deliver innovation?

Does Herantis Pharma Oyj have a chief innovation officer?

LockedSign up for free to unlock

Does Herantis Pharma Oyj disclose the ratio of CEO total compensation relative to average employee compensation ?

LockedSign up for free to unlock

Does Herantis Pharma Oyj disclose its gender pay gap?

Only SubscribersSubscription required
Does Herantis Pharma Oyj disclose its ethnicity pay gap?
Does Herantis Pharma Oyj disclose the number of employees in R&D functions?

Does Herantis Pharma Oyj engage in animal testing?

Only SubscribersSubscription required
Does Herantis Pharma Oyj engage in stem cell research?

Does Herantis Pharma Oyj have a commitment to a living wage?

LockedSign up for free to unlock

Does Herantis Pharma Oyj disclose the vesting schedule of its equity compensation plan?

LockedSign up for free to unlock
Is executive remuneration linked to climate performance?
Does Herantis Pharma Oyj offer flexible work?

Does Herantis Pharma Oyj disclose employee diversity metrics?

LockedSign up for free to unlock

Does Herantis Pharma Oyj disclose employee gender diversity metrics?

LockedSign up for free to unlock
Does Herantis Pharma Oyj disclose the pay ratio of women to men?
Does Herantis Pharma Oyj disclose incidents of non-compliance in relation to the health and safety impacts of products and services?

Does Herantis Pharma Oyj disclose information on fatalities and accidents in the workplace

Only SubscribersSubscription required
Does Herantis Pharma Oyj report instances of occupational ill health, injury and fatality?

Does Herantis Pharma Oyj disclose reportable workplace incidents?

LockedSign up for free to unlock

Does Herantis Pharma Oyj disclose the number of employees, new hires and turnover metrics?

Only SubscribersSubscription required
Does Herantis Pharma Oyj disclose parental leave metrics?

Does Herantis Pharma Oyj disclose employee training metrics?

LockedSign up for free to unlock
Does Herantis Pharma Oyj disclose the number of operations that have been subject to human rights reviews or human rights impact assessments?
Does Herantis Pharma Oyj disclose its policies for bribery, corruption, whistle-blower, conflict of interest?

Does Herantis Pharma Oyj disclose the number of customer privacy complaints?

Only SubscribersSubscription required
Does Herantis Pharma Oyj disclose incidents of discrimination?

Does Herantis Pharma Oyj disclose incidents relating human rights, child labour and forced labour?

LockedSign up for free to unlock

Does Herantis Pharma Oyj disclose incidents of corruption?

Only SubscribersSubscription required

Does Herantis Pharma Oyj disclose the number of incidents involving the rights of indigenous peoples?

LockedSign up for free to unlock

Does Herantis Pharma Oyj disclose incidents of non-compliance in relation to product and service information/labelling or marketing communications?

Only SubscribersSubscription required
Did Herantis Pharma Oyj have a product recall in the last two years?
Does Herantis Pharma Oyj support suppliers with sustainability related research and development?
Does Herantis Pharma Oyj have careers partnerships with academic institutions?
Is Herantis Pharma Oyj involved in embryonic stem cell research?

Does Herantis Pharma Oyj avoid gender bias in its hiring?

LockedSign up for free to unlock

Does Herantis Pharma Oyj disclose the number of hours and/or employees/security personnel trained on human rights policies or procedures?

LockedSign up for free to unlock

Have a different question?

Potential Risks for Herantis Pharma Oyj
These potential risks are based on the size, segment and geographies of the company.

Do you want to create your own ESG Scorecard that you can share with your team members?

Sign up for free
ESG Scorecard with Trendline
green chameleon

1/10 free views/searches used

You're viewing a Free Open ESG Rating.
To access the most comprehensive ESG data experience, Sign up to SEVVA Platform.

Herantis Pharma Oyj, a biotech company, engages in the development of disease-modifying CDNF-based therapies for Parkinson's disease (PD). Its lead product in pipeline includes HER-096, an advanced small and synthetic chemical peptidomimetic version of the active parent as the preclinical xCDNF candidate for the treatment of PD and other neurodegenerative diseases; and recombinant human Cerebral Dopamine Neurotrophic Factor (rhCDNF), a biological protein that is in Phase I study in patients with PD. The company was incorporated in 2008 and is based in Espoo, Finland.